Cite
Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium.
MLA
Wallner, Markus, et al. “Istaroxime, a Potential Anticancer Drug in Prostate Cancer, Exerts Beneficial Functional Effects in Healthy and Diseased Human Myocardium.” Oncotarget, vol. 8, no. 30, July 2017, pp. 49264–74. EBSCOhost, https://doi.org/10.18632/oncotarget.17540.
APA
Wallner, M., Khafaga, M., Kolesnik, E., Vafiadis, A., Schwantzer, G., Eaton, D. M., Curcic, P., Köstenberger, M., Knez, I., Rainer, P. P., Pichler, M., Pieske, B., & Lewinski, D. V. (2017). Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium. Oncotarget, 8(30), 49264–49274. https://doi.org/10.18632/oncotarget.17540
Chicago
Wallner, Markus, Mounir Khafaga, Ewald Kolesnik, Aris Vafiadis, Gerold Schwantzer, Deborah M Eaton, Pero Curcic, et al. 2017. “Istaroxime, a Potential Anticancer Drug in Prostate Cancer, Exerts Beneficial Functional Effects in Healthy and Diseased Human Myocardium.” Oncotarget 8 (30): 49264–74. doi:10.18632/oncotarget.17540.